Shifting focus towards the treatment of rare diseases is a factor driving the global transcranial magnetic stimulators market says Fortune Business insights in a report, titled “Transcranial Magnetic Stimulators Market Size, Share and Global Trend

Browse Complete Report [email protected]

Launch of Cobot – An Innovative Robot for Transcranial Magnetic Stimulation to Boost Market

Axium Robotics, a company based in Strasbourg, France, launched its TMS-Cobot TS MV, after receiving approval from the U.S and European regulatory authorities. The TMS-Cobot TS MV is a visual tracking system that allows to track the movement of patient and also offers uninterrupted adjusting of its positioning to maintain the coil’s focus on the target.

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Transcranial Magnetic Stimulators market. Some of the companies operating the global Transcranial Magnetic Stimulators market are;

  • Brainsway Ltd.
  • MagVenture A/S
  • Nexstim plc
  • Axilum Robotics
  • Neuronetics, Inc.
  • TMS Neuro Solutions
  • Magstim

Get PDF Brochure of this [email protected]

Increasing R&D Investment Will Create Growth Opportunities

Product launches along with rising R&D investments by key companies with a focus to treat rare diseases are expected to promote the transcranial magnetic stimulators market growth during the forecast period. Increasing number of regulatory approvals has led to the adoption of transcranial magnetic stimulators in emerging nations which in turn is boosting the transcranial magnetic stimulators market.

Increasing Demand for Advanced Stimulators Will Contribute to Growth in North America

Geographically, the global transcranial magnetic stimulators market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global transcranial magnetic stimulators market in 2018, and is expected to lead during the forecast period due to the presence of a large patient pool suffering from depression and other neurological disorders. Surge in the number of devices receiving regulatory approvals along with the rising demand for advanced stimulators and reimbursement policies are fostering growth in North America.

More Trending Topics From Fortune Business [email protected]

Medical Devices Market to Value US$ 602.1 Bn at CAGR of 5.3% by 2025 | Exclusive Report by Fortune Business Insights

Veterinary Therapeutics Market to Grow at 5.8% CAGR,Driven by Recent Developments in Veterinary Drugs, says Fortune Business Insights

About Us

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. 

Leave a Reply

Your email address will not be published. Required fields are marked *